AAAAAA

   
Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Journal of neuro-oncology

Results: 101-125/737

Authors: GLINSKI B DYMEK P SKOLYSZEWSKI J
Citation: B. Glinski et al., ALTERED THERAPY SCHEDULES IN POSTOPERATIVE TREATMENT OF PATIENTS WITHMALIGNANT GLIOMAS - 20 YEAR EXPERIENCE OF THE MARIA-SKLODOWSKA-CURIE-MEMORIAL-CENTER IN KRAKOW, 1973-1993, Journal of neuro-oncology, 36(2), 1998, pp. 159-165

Authors: RILEY MGI KIM NN WATSON VE GOBIN YP LEBEL CP BLACK KL BARTUS RT
Citation: Mgi. Riley et al., INTRAARTERIAL ADMINISTRATION OF CARBOPLATIN AND THE BLOOD-BRAIN-BARRIER PERMEABILIZING AGENT, RMP-7 - A TOXICOLOGIC EVALUATION IN SWINE, Journal of neuro-oncology, 36(2), 1998, pp. 167-178

Authors: BRANDES A CAROLLO C GARDIMAN M SCELZI E BOTTIN R ZAMPIERI P RIGON A FIORENTINO MV
Citation: A. Brandes et al., UNUSUAL NASAL AND ORBITAL INVOLVEMENT OF GLIOBLASTOMA-MULTIFORME - A CASE-REPORT AND REVIEW OF THE LITERATURE, Journal of neuro-oncology, 36(2), 1998, pp. 179-183

Authors: BATCHELOR TT PLATTEN M PALMERTOY DE HUNTER GJ LEV MH DALMAU J HOCHBERG FH
Citation: Tt. Batchelor et al., CHOREA AS A PARANEOPLASTIC COMPLICATION OF HODGKINS-DISEASE, Journal of neuro-oncology, 36(2), 1998, pp. 185-190

Authors: DROPCHO EJ ROSENFELD SS VITEK J GUTHRIE BL MORAWETZ RB
Citation: Ej. Dropcho et al., PHASE-II STUDY OF INTRACAROTID OR SELECTIVE INTRACEREBRAL INFUSION OFCISPLATIN FOR TREATMENT OF RECURRENT ANAPLASTIC GLIOMAS, Journal of neuro-oncology, 36(2), 1998, pp. 191-198

Authors: HAND CM VENDER JR BLACK P
Citation: Cm. Hand et al., CHEMOTHERAPY IN EXPERIMENTAL BRAIN-TUMOR, PART 1 - IN-VITRO COLORIMETRIC MTT ASSAY, Journal of neuro-oncology, 36(1), 1998, pp. 1-6

Authors: BLACK P HAND CM VENDER JR FINKELSTEIN SD
Citation: P. Black et al., CHEMOTHERAPY IN EXPERIMENTAL BRAIN-TUMOR, PART 2 - PRETREATMENT WITH LEUKOTRIENE C-4 PROLONGS SURVIVAL, Journal of neuro-oncology, 36(1), 1998, pp. 7-19

Authors: FORSYTH PA LAING TD GIBSON AW REWCASTLE NB BRASHER P SUTHERLAND G JOHNSTON RN EDWARDS DR
Citation: Pa. Forsyth et al., HIGH-LEVELS OF GELATINASE-B AND ACTIVE GELATINASE-A IN METASTATIC GLIOBLASTOMA, Journal of neuro-oncology, 36(1), 1998, pp. 21-29

Authors: TREDICI G TREDICI S FABBRICA D MINOIA C CAVALETTI G
Citation: G. Tredici et al., EXPERIMENTAL CISPLATIN NEURONOPATHY IN RATS AND THE EFFECT OF RETINOIC ACID ADMINISTRATION, Journal of neuro-oncology, 36(1), 1998, pp. 31-40

Authors: TAKI T OHNISHI T ARITA N HIRAGA S HAYAKAWA T
Citation: T. Taki et al., IN-VIVO ETOPOSIDE-RESISTANT C6 GLIOMA CELL-LINE - SIGNIFICANCE OF ALTERED DNA TOPOISOMERASE-II ACTIVITY IN MULTIDRUG-RESISTANCE, Journal of neuro-oncology, 36(1), 1998, pp. 41-53

Authors: GOMORI JM HECHING N SIEGAL T
Citation: Jm. Gomori et al., LEPTOMENINGEAL METASTASES - EVALUATION BY GADOLINIUM-ENHANCED SPINAL MAGNETIC-RESONANCE-IMAGING, Journal of neuro-oncology, 36(1), 1998, pp. 55-60

Authors: SALVATI M CERVONI L ARTICO M CARUSO R GAGLIARDI FM
Citation: M. Salvati et al., LONG-TERM SURVIVAL IN PATIENTS WITH SUPRATENTORIAL GLIOBLASTOMA, Journal of neuro-oncology, 36(1), 1998, pp. 61-64

Authors: BUCKNER JC BURCH PA CASCINO TL OFALLON JR SCHEITHAUER BW
Citation: Jc. Buckner et al., PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2A AND EFLORNITHINE INPATIENTS WITH RECURRENT GLIOMA, Journal of neuro-oncology, 36(1), 1998, pp. 65-70

Authors: HSIUNG CY LEUNG SW WANG CJ LO SK CHEN HC SUN LM FANG FM
Citation: Cy. Hsiung et al., THE PROGNOSTIC FACTORS OF LUNG-CANCER PATIENTS WITH BRAIN METASTASES TREATED WITH RADIOTHERAPY, Journal of neuro-oncology, 36(1), 1998, pp. 71-77

Authors: SALAME K MERIMSKY O YOSIPOV J REIDERGROSWASSER I CHAITCHIK S OUAKNINE GE
Citation: K. Salame et al., PRIMARY INTRAMEDULLARY SPINAL MELANOMA - DIAGNOSTIC AND TREATMENT PROBLEMS, Journal of neuro-oncology, 36(1), 1998, pp. 79-83

Authors: KIM M NA DL PARK SH JEON BS ROH JK
Citation: M. Kim et al., NERVOUS-SYSTEM INVOLVEMENT BY METASTATIC HEPATOCELLULAR-CARCINOMA, Journal of neuro-oncology, 36(1), 1998, pp. 85-90

Authors: BARTH RF
Citation: Rf. Barth, RAT-BRAIN TUMOR-MODELS IN EXPERIMENTAL NEUROONCOLOGY - THE 9L, C6, T9, F98, RG2 (D74), RT-2 AND CNS-1 GLIOMAS, Journal of neuro-oncology, 36(1), 1998, pp. 91-102

Authors: BLACK PM WESTPHAL M
Citation: Pm. Black et M. Westphal, PREFACE - GROWTH-FACTORS, GLIAL-CELLS AND NEUROONCOLOGY - PERSPECTIVES FOR TREATMENT, Journal of neuro-oncology, 35(3), 1997, pp. 189-190

Authors: NOBLE M MAYERPROSCHEL M
Citation: M. Noble et M. Mayerproschel, GROWTH-FACTORS, GLIA AND GLIOMAS, Journal of neuro-oncology, 35(3), 1997, pp. 193-209

Authors: PIETSCH T WIESTLER OD
Citation: T. Pietsch et Od. Wiestler, MOLECULAR NEUROPATHOLOGY OF ASTROCYTIC BRAIN-TUMORS, Journal of neuro-oncology, 35(3), 1997, pp. 211-222

Authors: FELDKAMP MM LAU N GUHA A
Citation: Mm. Feldkamp et al., SIGNAL-TRANSDUCTION PATHWAYS AND THEIR RELEVANCE IN HUMAN ASTROCYTOMAS, Journal of neuro-oncology, 35(3), 1997, pp. 223-248

Authors: CHICOINE MR SILBERGELD DL
Citation: Mr. Chicoine et Dl. Silbergeld, MITOGENS AS MOTOGENS, Journal of neuro-oncology, 35(3), 1997, pp. 249-257

Authors: ASHLEY DM BATRA SK BIGNER DD
Citation: Dm. Ashley et al., MONOCLONAL-ANTIBODIES TO GROWTH-FACTORS AND GROWTH-FACTOR RECEPTORS -THEIR DIAGNOSTIC AND THERAPEUTIC POTENTIAL IN BRAIN-TUMORS, Journal of neuro-oncology, 35(3), 1997, pp. 259-273

Authors: CAMPBELL JW POLLACK IF
Citation: Jw. Campbell et If. Pollack, GROWTH-FACTORS IN GLIOMAS - ANTISENSE AND DOMINANT-NEGATIVE MUTANT STRATEGIES, Journal of neuro-oncology, 35(3), 1997, pp. 275-285

Authors: KIRSCH M WILSON JC BLACK P
Citation: M. Kirsch et al., PLATELET-DERIVED GROWTH-FACTOR IN HUMAN BRAIN-TUMORS, Journal of neuro-oncology, 35(3), 1997, pp. 289-301
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>